Screener
Perspective Therapeutics CATX Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from Perspective Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Perspective Therapeutics’s 10-Q, filed November 12, 2024. Open the filing →
- Filed
- Nov 12, 2024
- Fiscal quarter
- Q4 FY2024
- Calendar quarter
- Q4 2024
- Accession
- 0000950170-24-125399
FAQ
- What is Perspective Therapeutics's gross margin?
- Perspective Therapeutics (CATX) reported gross margin of 33.1% in Q3 2023.
- How has Perspective Therapeutics's gross margin changed year-over-year?
- Perspective Therapeutics's gross margin decreased by 17.7% year-over-year, from 40.2% to 33.1%.
- What is the long-term trend for Perspective Therapeutics's gross margin?
- Over 2 years (2020 to 2022), Perspective Therapeutics's gross margin has grown at a -10.7% compound annual growth rate (CAGR), from 53.6% to 42.8%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.
Ask your AI about Perspective Therapeutics's gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude